PMR Predicts a Stable Outlook for the Pet Allergy Treatment Market Size Growth, Driven by Increasing Pet Ownership, Growing Awareness About Pet Allergies, and Advancements in Pet Treatment
Industry: Healthcare
Published Date: July-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 156
Report ID: PMRREP28603
The pet allergy treatment market is anticipated to rise from US$2.3 Bn in 2024 to US$3.9 Bn by the end of 2031. The market for pet allergy treatment is expected to reach a CAGR of 8.13% during the projection period from 2024 to 2031.
Key Highlights of the Market
|
Attributes |
Key Insights |
|
Market (2024E) |
US$2.3 Bn |
|
Projected Market Value (2031F) |
US$3.9 Bn |
|
Forecast Growth Rate (CAGR 2024 to 2031) |
8.13% |
|
Historical Growth Rate (CAGR 2019 to 2023) |
4.5% |
The pet allergy treatment market size is continuously expanding. It is expected to reach US$2.2 Bn in 2024. The market is witnessing an impressive rise of a CAGR of 8.13% in forecasted periods.
Pet allergies have become common across the globe. Some of the common allergies in pets include sneezing, skin irritations, itching, and stomach that are caused by environmental factors such as pollen, dust mites, and particular foods.
Several pet allergy treatments, such as medicines, allergen-specific immunotherapies, and hypoallergenic diets, are available.
The market for pet allergy therapies is fueled by several factors, such as increasing awareness of pet allergies and progress in veterinary allergology.
Advancements in determining specific allergens for animals, including dogs, cats, and horses, with a good knowledge of allergy conditions, have been achieved by developing animal-specific reagents.
New treatment methods, including silico-based or wet laboratory technologies, offer detailed information on pets' immune systems to find suitable diagnostic tools. This helps in pet dander allergy treatment or diagnosing other diseases that may occur frequently.
Further, to prevent the spread of these allergies to children, efficient immunotherapy and other novel pet allergy treatments for kids are being developed.
The pet allergy treatment market size has significantly expanded during 2019 and 2023, with more individuals interested in pet ownership and taking initiatives for their healthcare. This has created a push for pet allergies treatment, sparking a need for effective allergy solutions.
With advancements in immunotherapy and vaccinations, people are aware of several convenient diagnosis methods, like pet dander allergy skin rash treatment for their pets, including cat allergy treatment and dog allergy treatment.
Several trends and factors are propelling the market expansion. Increased disposable income is one of the key factors that pushes the market forward, as pet owners are inclined to invest in pet well-being.
Most dog owners are interested in opting for dog allergy treatment at home, which offers effective therapy and convenience to owners.
Further, increasing fund allocation for research and development, innovative therapies, and diagnosis options in pet allergy therapies are being incorporated to enhance pets' well-being and overall health.
Overall, the pet allergy treatment market is expected to reach US$3.9 Bn by 2031. These trends and advancements are further expected to create notable traction in the market.
Expanding Pet Population, and Growing Pet Ownership Rates
The increasing number of pets globally is a key driver for the pet allergy treatment market. As the trend of pet ownership is rising, the demand for products and services to manage pet allergies also increases.
A Pew Research Center survey shows that 62% of Americans own a pet, with 35% having multiple pets. This increasing number raises the prevalence of pet allergy treatment UK and US countries, necessitating effective treatment measures.
Growing Awareness About Pet Allergies
Growing awareness among pet owners about pet allergies creates the need for diagnosis and treatment. This increased awareness fuels innovation in the development of various products, such as medications, air purifiers, hypoallergenic pet supplies, and allergen-reducing cleaning solutions.
Some companies, such as The Humane Society of the United States, offer guidance on how to live with allergies and pets. They provide information on additional treatments for pet allergies, such as immunotherapy (allergy shots) and medication.
Development of Advanced Technologies
Investment in the development and research of advanced technologies provide beneficial opportunities for the growth of the pet allergy treatment market. These advancements help develop innovative products and services for managing pet allergies.
Limited Accessibility
The geographical location, economic differences, and limited healthcare infrastructure restrict the accessibility to treatments for pet allergies. This limited accessibility hinders the pet owners from obtaining proper diagnoses for their pets, hindering market growth.
Lack of Awareness
In several areas, particularly in rural areas, awareness about pet allergies is not spread. Despite increasing allergies, people remain unaware of effective treatments for allergies and their symptoms.
The lack of awareness in the majority of areas is one of the factors that is highly hindering market growth.
Regulatory Hurdles
Strict regulatory measures and approval from government bodies are another key barrier that is impeding the pet allergy treatment market from flourishing.
Developments and marketing of novel treatments and diagnosis services often undergo complex clinical trials for their sale, which is a time-consuming, costly, and extensive process for pet allergy treatment companies.
Sales of Antibiotics
Sales of antibiotics in the pet allergy treatment market are expected to generate substantial revenue. This indicates a potential growth opportunity for companies in this sector.
Novel advances and developments are fueling the acute demand for antibodies for pet allergies, which is driving market expansion.
Introduction to Immunotherapy
The growing awareness among healthcare professionals and patients regarding immunotherapy for the treatment of allergies is expected to create lucrative opportunities in the future.
Immunotherapy is a promising treatment option for pet allergies, and increased research and awareness about it can drive its adoption further.
Pet Allergy Immune Supplements
The pet allergy immune supplements market is projected to grow significantly in the coming years. These supplements are specifically formulated to support the immune system of pets suffering from allergies.
The market value is expected to reach a valuation of US$800 Mn by 2033, offering growth opportunities for companies in this segment.
Growing Focus on Sustainability
Pet owners are increasingly seeking safe, sustainable, and eco-friendly alternatives for pet grooming and care. This trend creates opportunities for the development and marketing of allergy treatment products that align with these preferences.
Antibiotics Lead the Drug Class Segment
Based on drug class, antibiotics are leading the market segment by acquiring 34.8% share of the global market in 2022. Antibiotics are gaining attention across the globe due to their higher efficacy against infections and allergies, thereby highly adopting by consumers.
Pets with allergies often suffer from some symptoms, such as ear infections or respiratory issues. In these scenarios, antibiotics play a vital role in alleviating the discomfort and facilitating the infection and complications.
Allergic Dermatitis to be the Leading Indication
Based on the indication, allergic dermatitis held over 75.4% share of the market in 2022. In allergic dermatitis, pets suffer from skin inflammation and irritation, which causes scratching, itching, redness, and discomfort.
As these signs are visible and affect the diet of pets that get noticed by owners, which allows for immediate treatment, and creates a strong demand for an effective diagnostic solution for these indications.
Heightened Dog Ownership Underpins Continued Dominance of the Dogs Category
Based on pet type, the pet category for dogs has achieved the highest market share of 51.2% in the global market in 2022. Dogs are being widely adopted globally due to their playful and loyal nature.
However, dogs are most vulnerable to several allergens, such as pollen, dust mites, and specific foods; they often catch allergies, which necessitates the dog allergy treatment for humans.
The increasing demand for effective treatment options tailored to dogs is driving the notable revenue in the market.
|
Countries |
Market Shares in 2022 |
|
United States |
30.9% |
|
China |
7.6% |
|
Germany |
7% |
Increasing Adoption of Pet Health Insurance in the US Adds Value to Dominance of the US
The United States is dominating the pet allergy treatment market by holding 30.9% share in 2022. This market growth is driven by increasing awareness and adoption of pet health insurance that simplifies the payment process for several veterinary services.
According to Animals Journal (Basel) 2020, the United States is leading the pet health insurance market with an impressive CAGR of 14.7% since 2014. This adoption of pet health insurance is boosted by the veterinary recommendations.
Another factor for this growth is the growing number of pet care products in the US. These wide range of products cater to pet owner’s preferences.
China's Developments in Smart Devices Creates Traction in Market
China accounted for 7.6% of market share in 2022, which is attributed to several key factors. China is known for its continuous technological advancements, which makes it prominent player in the market.
As more pets have become part of families in China, the country is focused on developing smart devices to keep track of pet allergy treatment for a baby or child in the house.
Smart devices use AI to monitor pets' health, helping pet owners determine the allegations and take prompt treatment action to protect children at home.
As pet owners are more interested in knowing their pet's wellbeing, pet allergy treatment is expected to grow further in China.
Advanced Pet Healthcare in Germany Facilitates Regional Growth
Germany accounted for 7% of market shares in 2022, which is influenced by various factors, such as increasing pet ownership, geographical variations, and advancements in the veterinary field.
The population of pet dogs in Germany has doubled since 2010, indicating a growing trend in pet ownership. Germany has a significant number of pets. The estimated number of pets in Germany, including dogs, cats, small animals, and cage birds, was around 34 million in 2022, among which dogs are over 10 million.
As pet owners are conscious about their pet’s health, they are inclined to invest in their pets' healthcare, contributing to increased market shares.
Further, changing environmental and climatic conditions in Germany contribute to several allergies to pets, leading to higher demand for diagnosis and effective treatment. Thus, driving the market growth notably.
December 2023
A study, CATNIP, funded by the NIH, found that a combination of allergy shots and another medication may be more effective in treating cat allergies. Cat allergens, tiny proteins found in cat skin, saliva, and urine, cause allergic reactions in humans. The CATNIP study involved 121 adults with a history of cat allergies and found that those who received the combined treatment had less severe symptoms, and some benefits lasted for at least one year after treatment ended.
November 2023
The American Animal Hospital Association (AAHA) has published the 2023 Management of Allergic Skin Diseases in Dogs and Cats Guidelines, aiming to provide a systematic approach to identifying and treating allergic skin diseases in these animals. The guidelines outline detailed diagnostic and treatment plans for flea allergy, food allergy, and atopy in dogs and flea allergy, food allergy, and feline atopic skin syndrome in cats. The guidelines emphasize a multimodal approach, separating acute and chronic conditions. Dr. Julia Miller, co-chair of the AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines Task Force, acknowledges the difficulty in consensus-building due to the numerous ways to manage allergic cases.
October 2023
French-Canadian pharmaceutical company Angany started the first clinical trial of a new vaccine candidate to treat cat allergies. The trial evaluates the vaccine's safety and ability to provoke an immune response in adults allergic to cat dander. There is no cure for cat allergies at present, but over-the-counter medicines can help relieve symptoms. Its trial has received an approval for lauch from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).
Companies like Zoetis Animal Healthcare, Merck and Co. Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, and Bayer AG are some of the leading players in the pet allergy treatment industry.
The prominent organizations aim to gain notable business growth by introducing new products and developments. They also focus on creating partnerships, acquisitions, joint ventures, and mergers to expand their market shares.
|
Attribute |
Details |
|
Forecast Period |
2024 to 2031 |
|
Historical Data Available for |
201 to 2022 |
|
Market Analysis |
US$ Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
By Drug Class:
By Indication:
By Pet Type:
By Route of Administration:
By Distribution Channel:
By Region:
To know more about delivery timeline for this report Contact Sales
The market is anticipated to grow from US$2.3 Bn in 2024 to US$3.9 Bn by the end of 2031.
Factors such as pet ownership, disposable income, advances in immunotherapy, and awareness about pet allergies are propelling market growth.
Zoetis Animal Healthcare, Boehringer Ingelheim GmbH, Merck and Co. Inc., Elanco Animal Health Incorporated, and Bayer AG are some of the leading players in the pet allergy treatment market.
The challenges, such as limited accessibility, lack of awareness about pet allergy treatment options, and regulatory hurdles, are restraining the market expansion.
Increasing sales of antibiotics, introduction to immunotherapy, growing sustainability, and availability of pet allergy immune supplements are the key opportunities in the market.
